DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bromerguride
Bromerguride
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
)&F1y3x PHARMACEUTICAL APPENDIX to THE
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
Inverse Agonism at Dopamine D2 Receptors: a Receptor Recalcitrant to High Levels of Constitutive Activation* Thierry Wurch*, Elisa A
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Download Product Insert (PDF)
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
Stembook 2018.Pdf
Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach
Customs Tariff - Schedule
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
TAR/W/87 21 Juin 1993 DOUANIERS ET LE COMMERCE Distribution Limitée
Pharmaceutical Appendix to the Tariff Schedule 2
Customs Tariff - Schedule Xxi - 1
Top View
2. Serotonin 5-HT1A Receptor Signalling: G-Protein Activation
Human Neurogenesis Assay: Ramelteon
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
General Agreement on Tariffs Andtrade
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ERGOT: the Genus Claviceps
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 7,678,808 B2 Barlow Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
The Effect of Neuregulin 1 on PCP Induced Alterations of Locomotion, Neurotransmission and Cell Growth As Relevant for Schizophr
Pharmaceuticals Appendix
United States Patent (19) 11 Patent Number: 6,037,360 Smith Et Al
92975 Brevet D'invention B1
United States Patent (19) 11 Patent Number: 5,922,341 Smith Et Al
Schedule Clxxiii - European Union
Pharmacogenetic Analysis of Dopamine and Glutamate Receptor Gene Polymorphisms and Clinical Response to Clozapine in Patients with Schizophrenia